Skip to main content
. Author manuscript; available in PMC: 2022 Mar 22.
Published in final edited form as: J Hum Resour. 2019 Nov 13;56(4):997–1030. doi: 10.3368/jhr.56.4.1115-7543r5

Table 6:

Depression Score and Symptoms

CES-D Score Any Symptoms
[1] [2] [3] [4]

Full Sample
HAART available −2.734*** −3.328*** −0.017 −0.080***
(0.441) (0.507) (0.016) (0.018)
Treatment Group −2.406*** −2.507*** −0.016 −0.022
(0.871) (0.872) (0.030) (0.029)
Treatment × HAART 0.501 0.803 0.011 0.028
(0.720) (0.718) (0.027) (0.026)
Obs. 14324 14324 16765 16765

Pre-HAART treatment group mean 16.55 16.55 0.45 0.45
Mean 15.95 15.95 0.44 0.44
R2 0.010 0.043 0.000 0.037

Black Sample
HAART available −3.478*** −4.223*** −0.004 −0.068***
(0.611) (0.666) (0.021) (0.023)
Treatment Group −3.398*** −3.074*** 0.023 0.026
(1.067) (1.056) (−.040) (0.038)
Treatment 00D7 HAART 1.486 1.702* −0.045 −0.026
(0.940) (0.936) (0.035) (0.034)
Obs. 8205 8205 9608 9608

Pre-HAART treatment group mean 15.97 15.97 0.48 0.48
Mean 15.69 15.69 0.44 0.44
R2 0.014 0.053 0.001 0.050

Basic Controls N Y N Y

This table shows estimates from OLS difference-in-differences models. The first outcome variable is CES-D Scale Score, where higher values mean depression is more likely. The second outcome is having any symptom (fever, memory problem, numbness, weight loss, mental confusion, or night sweats). Results for having any symptom are robust to a probit specification, and available upon request. Basic controls include age at visit, age squared, age cubed, race (Caucasian omitted), and site of visit (Chicago omitted). In all specifications, errors are clustered at the individual level.